Grace Therapeutics (L8S.F) Q3 2024 Earnings

9AugConfirmed
Q3 2024
-0.24
-0.24
-0.23
-0.22

Details

Expected EPS
-0.24275325000000003
Actual EPS
-0.219852
Surprise EPS
0.02
Surprise Percent
+9.43%

Description

Grace Therapeutics (L8S.F) has reported earnings of -0.219852 per share for Q3 2024.

0 Comments

Share your thoughts